Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis.

Ma, Wenhua; Zhao, Fugang; Zhou, Changpeng; Zhang, Yongqian; Zhao, Yingchun; Li, Na; Xie, Peng

Ma, Wenhua; Zhao, Fugang; Zhou, Changpeng; Zhang, Yongqian; Zhao, Yingchun; Li, Na; Xie, Peng.

Afiliación

Ma W; Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Zhao F; Department of Traditional Chinese Medicine, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Zhou C; Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Zhang Y; Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Zhao Y; Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Li N; Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.
Xie P; Department of Nuclear Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China, woxinfly1982@126.com.

Onco Targets Ther ; 12: 379-390, 2019.

Article en En | MEDLINE | ID: mdl-30655674

Palabras clave

HER-2-positive; breast cancer; lapatinib; neoadjuvant; trastuzumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Tipo de estudio: Systematic_reviews Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google